Kyron.bio Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $6.2M

  • Investors
  • 16

Kyron.bio General Information

Description

Operator of a bioproduction platform intended to produce cheap and novel biopharmaceuticals. The company's platform leverages patentable technology that boosts the effectiveness and yield of therapeutic proteins produced in mammalian cell factories by harnessing efficient processes from diverse organisms to precisely control the glycosylation pattern on the surface of a biologic for developing medicines, enabling the bioproduction industry to revolutionize drug production.

Contact Information

Website
www.kyron.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Paris Biotech Santé-Site Cochin
  • 27 rue du Faubourg Saint Jacques
  • 75014 Paris
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Paris Biotech Santé-Site Cochin
  • 27 rue du Faubourg Saint Jacques
  • 75014 Paris
  • France

Kyron.bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kyron.bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Seed Round 28-May-2025 $6.2M Completed Generating Revenue
14. Grant 01-Jan-2025 Completed Generating Revenue
13. Accelerator/Incubator Completed Generating Revenue
12. Grant 31-Jan-2024 Completed Generating Revenue
11. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
10. Accelerator/Incubator 01-May-2023 Completed Generating Revenue
9. Grant 01-Jan-2023 Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
7. Grant 01-Jan-2023 $79.5K $1.84M Completed Generating Revenue
6. Seed Round $1.25M $1.84M Completed Generating Revenue
To view Kyron.bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Kyron.bio Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Kyron.bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202505322-D0 Antibody drug conjugate and methods Pending 09-Apr-2025
EP-4733319-A1 Therapeutic molecules Pending 25-Oct-2024

Kyron.bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kyron.bio Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alven Capital Partners Venture Capital Minority
HCVC VC-Backed Company Minority
Saras Capital Hedge Fund Minority
Verve Ventures Venture Capital Minority
European Innovation Council Accelerator/Incubator
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

Kyron.bio FAQs

  • When was Kyron.bio founded?

    Kyron.bio was founded in 2022.

  • Where is Kyron.bio headquartered?

    Kyron.bio is headquartered in Paris, France.

  • What is the size of Kyron.bio?

    Kyron.bio has 8 total employees.

  • What industry is Kyron.bio in?

    Kyron.bio’s primary industry is Drug Discovery.

  • Is Kyron.bio a private or public company?

    Kyron.bio is a Private company.

  • What is the current valuation of Kyron.bio?

    The current valuation of Kyron.bio is .

  • What is Kyron.bio’s current revenue?

    The current revenue for Kyron.bio is .

  • How much funding has Kyron.bio raised over time?

    Kyron.bio has raised $8.05M.

  • Who are Kyron.bio’s investors?

    Alven Capital Partners, HCVC, Saras Capital, Verve Ventures, and European Innovation Council are 5 of 16 investors who have invested in Kyron.bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process